Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2 Other hematologic neoplasm 1 Head & Neck 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 3 Nausea 1

Interventions

Aprepitant 6 Dexamethasone 4 Calcium Dobesilate 4 Therapeutics 3 Palonosetron 3 Granisetron 3 Cyclophosphamide 3 netupitant 2 Yoga 2 Sugars 2 Psychiatric Rehabilitation 2 Ondansetron 2 Electroacupuncture 2 Duration of Therapy 2 stinging nettle lectin 1 sinomenine 1 peppermint oil 1 netupitant, palosentron drug combination 1 fosaprepitant 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 Surveys and Questionnaires 1 Prochlorperazine 1 Olanzapine 1 Massage 1 Lactose 1 Immunoenzyme Techniques 1 Hypnosis 1 Hygiene 1 Growth Differentiation Factor 15 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nausea × Olanzapine × Breast × Clear all

NCT04669132 2022-02-23

OLNEPA

Instituto Brasileiro de Controle do Cancer

Phase 2 Completed

Breast Neoplasms, Nausea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡